Abstract
Chemokines are a small family of cytokines that were first discovered as chemotactic factors in leukocytes during inflammation, and reports on the relationship between chemokines and cancer progression have recently been increasing. The CCL2-CCR2 axis is one of the major chemokine signaling pathways, and has various functions in tumor progression, such as increasing tumor cell proliferation and invasiveness, and creating a tumor microenvironment through increased angiogenesis and recruitment of immunosuppressive cells. This review discusses the roles of the CCL2-CCR2 axis and the tumor microenvironment in cancer progression and their future roles in cancer therapy.
Highlights
Published: 8 August 2021The tumor microenvironment (TME) is an important factor in the growth and progression of cancer and comprises a wide variety of cells, including cancer cells, immune cells, stromal cells, and epithelial cells [1]
Chemokines have been widely reported in autoimmune-related diseases, but, in recent years, more reports have linked these to the control of cancer in the TME [3]
Chemokines induce cytotoxic T lymphocytes into tumor tissues and exhibit anticancer effects, they induce cells that suppress tumor immunity, such as the tumor-associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) [3,4]
Summary
The tumor microenvironment (TME) is an important factor in the growth and progression of cancer and comprises a wide variety of cells, including cancer cells, immune cells, stromal cells, and epithelial cells [1]. Chemokines induce cytotoxic T lymphocytes into tumor tissues and exhibit anticancer effects, they induce cells that suppress tumor immunity, such as the tumor-associated macrophage (TAM) and myeloid-derived suppressor cell (MDSC) [3,4]. Among these chemokines, we report on CCL2, which has been shown to play essential roles in the TME, and its main receptor, CCR2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.